HHV8 抗体
Our Local Distributor
北京 101111
Quick Overview for HHV8 抗体 (ABIN115219)
抗原
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
交叉反应 (详细)
- Species reactivity (tested):Human.
-
纯化方法
- Purified
-
免疫原
- Recombinant protein corresponding to the latent nuclear antigen-1 molecule of HHV8.
-
亚型
- IgG2c
-
-
-
-
应用备注
-
Immunohistochemistry: Use at 1/25-1/50 dilution in an ABC method (30 to 60 minutes atroom temperature). Formalin fixed paraffin embedded tissue sections require high temperature antigenunmasking with 10 mM citrate buffer, pH 6.0 prior to immunostaining. Recommended Positive Control: Kaposi's sarcoma.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Sodium Azide
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- Store the antibody undiluted at 2-8 °C.
-
-
- HHV8 (Herpes Virus Type 8 (HHV8))
-
别名
- Herpes Virus Type 8 / HHV8
-
物质类
- Virus
-
背景
- HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.Synonyms: HHV-8, KHSV
抗原
-